0001179110-16-026230.txt : 20160608 0001179110-16-026230.hdr.sgml : 20160608 20160608190038 ACCESSION NUMBER: 0001179110-16-026230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160608 FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allergan plc CENTRAL INDEX KEY: 0001578845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 BUSINESS PHONE: (216) 523-5000 MAIL ADDRESS: STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK CITY: COOLOCK, DUBLIN STATE: L2 ZIP: D17 E400 FORMER COMPANY: FORMER CONFORMED NAME: Actavis plc DATE OF NAME CHANGE: 20130930 FORMER COMPANY: FORMER CONFORMED NAME: Actavis Ltd DATE OF NAME CHANGE: 20130607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHAISON PHILIPPE CENTRAL INDEX KEY: 0001637140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36867 FILM NUMBER: 161704575 MAIL ADDRESS: STREET 1: C/O ACTAVIS PLC MORRIS CORP CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0306 4 2016-06-08 1 0001578845 Allergan plc AGN 0001637140 SCHAISON PHILIPPE CLONSHAUGH BUSINESS AND TECHNOLOGY PARK, COOLOCK, CO. DUBLIN L2 00000 IRELAND 0 1 0 0 EVP, President Allergan Med Ordinary Shares, par value $0.0001 8620 D Stock Option (Right to Buy) 112.2 2023-10-31 Ordinary Shares 16152 16152 D Stock Option (Right to buy) 154.87 2024-02-21 Ordinary Shares 16387 16387 D Stock Option (Right to buy) 289.75 2025-02-20 Ordinary Shares 8149 8149 D Stock Option (Right to buy) 307.51 2025-03-17 Ordinary Shares 8676 8676 D Performance Based Restricted Stock Unit Ordinary Shares 9344 9344 D Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Vests in four equal annual installments commencing on the first anniversary of the grant date (October 31, 2013). Vests in four equal annual installments commencing on the first anniversary of the grant date (February 21, 2014). Vests in four equal annual installments commencing on the first anniversary of the grant date (February 20, 2015). Vests in five equal annual installments commencing on the first anniversary of the grant date (March 17, 2015). Represents performance-based restricted share units ("PSUs") which will vest as to one-third of the total grant on each of December 31, 2017, 2018 and 2019, subject to the achievement by the Issuer of certain performance criteria. Each PSU represents a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person. /s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person 2016-06-08